Texas Permanent School Fund’s Cytek Biosciences CTKB Stock Holding History

Texas Permanent School Fund’s Portfolio CTKB Stock Details CTKB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-86,601	Closed	-$581K	–	342
2024 Q1	$581K	Buy	86,601 +1,702	+2%	+$13.5K	﹤0.01%	1444
2023 Q4	$774K	Buy	84,899 +379	+0.4%	+$2.38K	0.01%	1369
2023 Q3	$467K	Buy	84,520 +14,052	+20%	+$113K	﹤0.01%	1445
2023 Q2	$602K	Buy	+70,468	New	+$632K	0.01%	1404

Other funds holding CTKB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Texas Permanent School Fund's CTKB Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Cytek Biosciences (CTKB) in Q2 2024, closing a stake of 86,601 shares — an estimated $581K sold.

Texas Permanent School Fund first reported a position in CTKB in Q2 2023 and held it in 4 quarters. The position peaked at $774K in Q4 2023. 128 funds tracked by Wall St. Rank hold CTKB as of Q2 2024.

Texas Permanent School Fund reported no remaining Cytek Biosciences position as of Q2 2024 after selling out during the quarter.
Texas Permanent School Fund sold 86,601 Cytek Biosciences shares in Q2 2024, an estimated $581K.
Texas Permanent School Fund first reported a position in Cytek Biosciences in Q2 2023 and held it in 4 quarters.
Texas Permanent School Fund's Cytek Biosciences position peaked at $774K in Q4 2023.
128 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.